Pfizer is looking to raise the price of COVID-19 vaccines by up to four times once Washington's purchase program ends
- The federal government is paying roughly $30 per dose for the vaccine. When the government purchase program shuts down, Lukin expects a dose to be priced around $110 to $130.
- In 2021, Pfizer made almost $37 billion through COVID vaccine sales, with overall revenues doubling to $81.3 billion. The company is expecting revenues to reach $98 billion to $102 billion this year.
Shrinking Market, Vaccine Dangers
- Vaccine manufacturers will have to raise prices significantly to meet revenue expectations that Wall Street has for 2023 and the years ahead
- There are also growing worries about the potential side effects of the COVID-19 vaccines which could dampen the market
- Recently, Florida Surgeon General Dr. Joseph A. Ladapo issued new guidance on mRNA COVID vaccines like those manufactured by Pfizer
No comments:
Post a Comment